BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20477051)

  • 1. Novel approaches in the management of refractory celiac disease.
    Verbeek WH; Schreurs MW; Visser OJ; von Blomberg BM; Al-Toma A; Mulder CJ
    Expert Rev Clin Immunol; 2008 Mar; 4(2):205-19. PubMed ID: 20477051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
    Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
    Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of complicated celiac disease.
    Al-toma A; Verbeek WH; Mulder CJ
    Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
    Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
    Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
    Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
    Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gluten sensitivity in the rectal mucosa of first-degree relatives of celiac disease patients.
    Dezi R; Niveloni S; Sugai E; Pedreira S; Smecuol E; Vazquez H; Doldan I; Cabanne A; Boerr L; Valero J; Kogan Z; Mauriño E; Bai JC
    Am J Gastroenterol; 1997 Aug; 92(8):1326-30. PubMed ID: 9260799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease.
    Verbeek WH; von Blomberg BM; Scholten PE; Kuik DJ; Mulder CJ; Schreurs MW
    Am J Gastroenterol; 2008 Dec; 103(12):3152-8. PubMed ID: 19086962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and long-term outcome of patients with refractory sprue diagnosed at a single institution.
    Mauriño E; Niveloni S; Cherñavsky AC; Sugai E; Vázquez H; Pedreira S; Periolo N; Mazure R; Smecuol E; Moreno ML; Litwin N; Nachman F; Kogan Z; Bai JC
    Acta Gastroenterol Latinoam; 2006 Mar; 36(1):10-22. PubMed ID: 16706073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in refractory coeliac disease: a review.
    Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P
    Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery.
    Wahab PJ; Meijer JW; Mulder CJ
    Am J Clin Pathol; 2002 Sep; 118(3):459-63. PubMed ID: 12219789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
    de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
    Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiac disease.
    Leffler D; Saha S; Farrell RJ
    Am J Manag Care; 2003 Dec; 9(12):825-31; quiz 832-3. PubMed ID: 14712759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease.
    Cellier C; Cervoni JP; Patey N; Leborgne M; Marteau P; Landi B; Cerf-Bensussan N; Barbier JP; Brousse N
    Am J Gastroenterol; 1998 Sep; 93(9):1527-30. PubMed ID: 9732937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enteropathy-associated T-cell lymphoma. Manifestation as diet-refractory coeliac disease and ulcerating jejunitis].
    Bächle T; Rühl U; Ott G; Walker S
    Dtsch Med Wochenschr; 2001 Dec; 126(51-52):1460-3. PubMed ID: 11753737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cladribine therapy in refractory celiac disease with aberrant T cells.
    Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory coeliac disease.
    Daum S; Cellier C; Mulder CJ
    Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiac disease: diagnosis, autoimmune mechanisms and treatment.
    Gill BM; Leffler DA
    Expert Rev Clin Immunol; 2007 Sep; 3(5):763-72. PubMed ID: 20477026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.
    Kurppa K; Collin P; Viljamaa M; Haimila K; Saavalainen P; Partanen J; Laurila K; Huhtala H; Paasikivi K; Mäki M; Kaukinen K
    Gastroenterology; 2009 Mar; 136(3):816-23. PubMed ID: 19111551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gluten challenge in borderline gluten-sensitive enteropathy.
    Wahab PJ; Crusius JB; Meijer JW; Mulder CJ
    Am J Gastroenterol; 2001 May; 96(5):1464-9. PubMed ID: 11374684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
    Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.